Tamer Abdelgawad

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid
    Matthew M Murawski
    Department of Pharmacy Practice, Purdue University School of Pharmacy and Pharmacal Sciences, West Lafayette, IN 47907 2051, USA
    Am J Manag Care 11:SP35-42. 2005
  2. ncbi Preferred drug lists and Medicaid prescriptions
    Tamer Abdelgawad
    Pfizer Inc, New York, NY 10017, USA
    Pharmacoeconomics 24:55-63. 2006

Collaborators

Detail Information

Publications2

  1. ncbi Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid
    Matthew M Murawski
    Department of Pharmacy Practice, Purdue University School of Pharmacy and Pharmacal Sciences, West Lafayette, IN 47907 2051, USA
    Am J Manag Care 11:SP35-42. 2005
    ....
  2. ncbi Preferred drug lists and Medicaid prescriptions
    Tamer Abdelgawad
    Pfizer Inc, New York, NY 10017, USA
    Pharmacoeconomics 24:55-63. 2006
    ..When Medicaid preferred drug lists (PDLs) are implemented, they may impose indirect costs on prescribing physicians and Medicaid patients, leading to an unintended reduction in the number of Medicaid prescriptions filled...